CXCR4 and non-small cell lung carcinoma: In NSCLC, we previously showed that the population of CD133+/CXCR4+ MICs is endowed with stemness and EMT features, enhanced resistance to cisplatin, and superior ability to seed distant organs and initiate metastasis (11, 13).